ExodusPoint Capital Management, LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2022$519,000
-7.2%
396,362
+24.7%
0.01%
+16.7%
Q4 2021$559,000
-46.6%
317,800
-34.2%
0.01%
-57.1%
Q3 2021$1,047,000
+705.4%
482,663
+1202.2%
0.01%
+1300.0%
Q2 2021$130,000
-0.8%
37,064
+206.0%
0.00%0.0%
Q4 2020$131,000
-39.6%
12,112
+16.6%
0.00%
-83.3%
Q2 2020$217,00010,3840.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,109,867$42,332,00029.76%
Versant Venture Management, LLC 7,003,892$72,140,00013.20%
Ghost Tree Capital, LLC 1,161,375$11,962,0003.46%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,944,0002.54%
Soleus Capital Management, L.P. 364,349$3,753,0001.99%
RTW INVESTMENTS, LP 7,234,764$74,518,0001.79%
RA Capital Management 9,410,860$96,932,0001.77%
FRAZIER MANAGEMENT LLC 1,437,028$14,801,0001.33%
Casdin Capital, LLC 2,750,000$28,325,0001.27%
Avoro Capital Advisors LLC 8,000,000$82,400,0001.17%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders